Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AURA compared with VOR: revenue, margins and what each company keeps, and the suppliers and customers both name
AURA
Aura Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
VOR
Vor Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AURA
Aura Biosciences, Inc.
vs
VOR
Vor Biopharma Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AURA: latest quarter not drawable. VOR: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AURA
0
None
Shared
0
No disclosed counterparties: AURA.
Only VOR
3
—
RemeGen
unlisted
supplier
—
The Trustees of Columbia University in the City of New York
unlisted
customer
—
U.S. Department of Health and Human Services, as represented by National Cancer Institute of the National Institutes of Health
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
AURA
Aura Biosciences, Inc.
Change
6.64
▲
+6.49%
· post 6.64
· delayed
Mkt cap
$647.1M
VOR
Vor Biopharma Inc.
Change
19.94
▲
+0.42%
· post 20.19
· delayed
After hours
Nov 4 '26
delayed
Mkt cap
$1.2B
vs
Compare
After hours
Nov 4 '26
delayed
AURA
Aura Biosciences, Inc.
vs
VOR
Vor Biopharma Inc.
6.64
▲
+6.49%
post 6.64
delayed
Price
19.94
▲
+0.42%
post 20.19
delayed
$647.1M
Mkt cap
$1.2B
Change
Change
AURA
6.64
▲
+6.49%
vs
VOR
19.94
▲
+0.42%
After hours
Nov 4 '26
delayed
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AURA, solid
VOR, dashed